New system delivers drug straight into tumours with fewer side effects
A new drug delivery system disguises chemo-therapeutics as fat in order to destroy tumours.
List view / Grid view
A new drug delivery system disguises chemo-therapeutics as fat in order to destroy tumours.
Global active pharmaceutical ingredients market set to surpass US$274.9 billion by 2026.
The US Food and Drug Administration (FDA) has approved Piqray (alpelisib) tablets to treat patients with breast cancer.
The retail prices of some anti-cancer drugs have been cut by 87 percent by the drug price control authority in India.
The CMA accuses four pharmaceutical firms of colluding to illegally inflate prices of an anti-nausea drug.
A brain-cancer vaccine more than 20 years in the making suspends cancer growth in patients enrolled in early-stage trial...
A report has forecasted that the generic oncology drugs market could register an impressive 6 percent CAGR up to the year 2028...
The role of personalised and precision medicine may be ideal for the treatment of cancer, but questions about consequences and society issues still remain...
A study has reported that almost 40 percent of patients with non-surgically treatable tumours were effectively treated using a genetically modified virus...
Results did not confirm the clinical benefit of Lartruvo in combination with doxorubicin compared to doxorubicin alone…
A clinical trial to analyse breath for volatile organic compounds to detect different types of cancer has been launched by Cancer Research UK...
A sprayable gel containing calcium carbonate nanoparticles with antibodies targeted to block CD47, could be the future of drug delivery for cancer...
Through a clinical trial, Cleveland researchers have identified how rivaroxaban reduces blood clots in cancer patients and also decreases related deaths...
A nanoscale blood test could be used to gain more information from the blood of patients in order to help the identification of cancer in its early stages...
A trial has shown that radiotherapy is more effective when levels of ropidoxuridine in a patients' body reach a certain level...